Circulate Health offers FDA-cleared Therapeutic Plasma Exchange (TPE) treatment for deceleration in human biological age and age-related biological pathways.
Location: United States
Total raised: $12M
Investors 1
| Date | Name | Website |
| 10.07.2025 | Seaside Ve... | seasideven... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.07.2025 | Seed | $12M | - |
Mentions in press and media 5
| Date | Title | Description |
| 03.12.2025 | Circulate Health Secures Strategic Investment from Scrum Ventures to Scale TPE and Microplastics Removal Technology | What You Should Know: – Circulate Health, a pioneer in Therapeutic Plasma Exchange (TPE) technologies, has secured a seven-figure strategic investment from Scrum Ventures. – The funding will accelerate the company’s growth as it works to po... |
| 03.12.2025 | Circulate Health Receives Strategic Investment from Scrum Ventures | Circulate Health, a Novato, CA-based company which specializes in precision Therapeutic Plasma Exchange (TPE) technologies and microplastics technologies, received an Investment from Scrum Ventures. The amount of the deal was not disclosed.... |
| 09.10.2025 | Microplastics Are in Our Blood—Why Aren’t Federal Regulators Acting? | Dr. Brad Younggren, CEO of Circulate Health Microplastics are highly prevalent in the United States, contaminating various environmental compartments and even entering the human body. Studies have found microplastics in food, water, and air... |
| 02.07.2025 | Circulate Health Raises $12M in Seed Funding | Circulate Health, a Novato, CA-based longevity startup which specializes in therapeutic plasma exchange (TPE) to advance human healthspan and lifespan, raised $12M in Seed funding. The round was led by Khosla Ventures with participation fro... |
| - | Circulate | “Home | Circulate Health” |